Share on StockTwits

CONMED (NASDAQ:CNMD) EVP William Abraham sold 15,986 shares of the stock on the open market in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $37.71, for a total value of $602,832.06. Following the sale, the executive vice president now directly owns 8,909 shares of the company’s stock, valued at approximately $335,958. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Separately, analysts at Zacks reiterated a “neutral” rating on shares of CONMED in a research note on Friday, July 18th. They now have a $44.00 price target on the stock.

Shares of CONMED (NASDAQ:CNMD) traded down 0.05% on Friday, hitting $37.58. The stock had a trading volume of 117,604 shares. CONMED has a one year low of $30.86 and a one year high of $50.47. The stock’s 50-day moving average is $40.05 and its 200-day moving average is $44.0. The company has a market cap of $1.028 billion and a P/E ratio of 30.10.

CONMED (NASDAQ:CNMD) last released its earnings data on Wednesday, July 23rd. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.47. The company had revenue of $188.20 million for the quarter, compared to the consensus estimate of $190.62 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was down 2.5% on a year-over-year basis. Analysts expect that CONMED will post $1.87 EPS for the current fiscal year.

CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.

Receive News & Ratings for CONMED Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Co and related companies with Analyst Ratings Network's FREE daily email newsletter.